A $4.1 billion buy of drugs targeting rare mutations; FDA scientists weigh in on Novavax vaccine

Taking stock of the drug industry, from the lab to the medicine chest ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Sponsored by     STAT+: Bristol Myers Squibb to buy Turning Point Therapeutics for $4.1 billion to gain drugs targeting rare cancer mutations By Matthew Herper Courtesy Bristol Myers Squibb The acquisition gives Bristol a biotech that is developing medicines that fight cancer by targeting specific mutations. Read More FDA scientists say Novavax's Covid-19 vaccine is effective, but also raise concerns By Matthew Herper JUSTIN TALLIS/AFP via Getty Images Scientists questioned how effective the vaccine is against currently circulating strains — and raised concerns about a rare side effect. Read More STAT+: Up and down the ladder: The latest comings and goings By Ed Silverman Alex Hogan/STAT From new hires to departures, promotions, and transfers, here are the latest comings and goings in the pharma industry. Read More Sponsor content by NEW YORK CITY ECONOMIC DEVELOPMENT CORPORATION NYC: an R&D and innovation hub, powered by diversity and $1B public investment With an unmatched range of sciences and a diverse population of 8 million+, NYC is a unique ecosystem for innovation and R&D. LifeSci NYC is a $1B city initiative to support the industry and help companies expand, grow, and succeed. Discover more about life sciences in NYC. STAT+: Strategist Jared Holt on why innovation may not be such a good thing for the biotech sector By Meg Tirrell and Adam Feuerstein and Damian Garde Spencer Platt/Getty Images A health care strategist with Oppenheimer discusses the downturn in biotech stocks and what it means for the industry. Read More Friday, June 3, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser